Copy
LISAvienna Newsletter 09/2016 – Get Connected
Is this email not displaying correctly?
View it in your browser


 

News November 2016

Dear reader!
 
Vienna is a great place for doing business and starting up a company. Check out what the winners of the Vienna Business Agency’s video competition appreciate most and play their video now!
 
As you know, it is conference and trade fair season again. This week, we are available at four major events in Düsseldorf, Graz and Vienna including Medica and the Partnerships for Clinical Trials Europe Conference. Get in touch to discuss lab space and collaboration partners that are waiting for you in Vienna.
 
Read below for some recent life sciences news. Please also find our update on events and opportunities for funding and support included.

Happy reading!
LISAvienna

BIOTECH & PHARMA

Arsanis to announce key publications supporting its monoclonal antibody program
Two publications confirm the activity of the human monoclonal antibodies that comprise Arsanis’ lead clinical candidate, ASN100, targeted against Staphylococcus aureus pneumonia. The company also has presented data from a prospective epidemiology study at IDWeek 2016 recently.
Hookipa Biotech secures 4.16 million euros in additional grant support from FFG
The grant will be used to further substantiate the broad applicability of Hookipa’s arenaviral vector technologies for innovative cancer immunotherapies and to progress the development of the lead oncology product HB201 for the treatment of HPV-associated head and neck cancer.
Lexogen: RNA-Seq Research Award
With the “Controlling RNA-Seq Experiments Using SIRVs“ Award, the company wants to provide a chance for researchers to utilize more next generation sequencing (NGS) in upcoming projects. Apply by November 21, 2016 and win a set of Spike-in RNA Variant Control Mixes (SIRVs) together with one sequencing run.
Nabriva Therapeutics presents update on Lefamulin at IDWeek 2016
Two posters dealing with the two ongoing global phase 3 clinical trials investigating lefamulin treatment in patients with moderate-to-severe Community Acquired Bacterial Pneumonia discuss dose selection for IV and oral dosing and optimal sampling strategies.
Valneva reports strong business performance in first nine months
Total revenues and grants grew to 70.7 million euros in the first nine months of 2016 benefiting from a more than 60% increase of IXIARO®/JESPECT® revenues. Based on the company’s strong year to date financial performance, Valneva raises its FY 2016 operating guidance.

MEDTECH

Miracor Medical receives additional funding in Series-C
This allows expanding clinical and commercial activities with the PiCSO Impulse System. The closing was led by Peppermint with existing investors also participating. The total amount raised reaches up to 7 million euros. Miracor also announced the appointment of Olivier Delporte as the new CEO.
SCARLETRED to win WKW’s Mercur Award 2016 for life sciences
The award honors the company’s first of its kind skin imaging platform SCARLETRED®VISION as most innovative technology in the category life sciences. At the same time, it qualifies SCARLETRED to be nominated for the Austrian National Award for Innovation.
European innovation award EARTO 2016 goes to Semperit
At this year's ASBMR meeting in Atlanta (Georgia), TAmiRNA presented the new osteomiR™ test kit – a unique molecular diagnostic kit for detection of osteoporosis. For now, the kit is for research-use only. Tests for routine clinical use will start soon.

ACADEMIC News

CeMM and MedUni Vienna: Missing link between hemolysis and infection found
IMP: Researchers watch in 3D as neurons talk to each other in a living mouse brain
LBG: Interim results of LEAD study on COPD: alarming results on lung development in children
MedUni Vienna: Innovative drug could revolutionize the treatment of early-stage breast cancer
TU Wien: Austrian Computer Graphics Award for ”Cellview"
Read more news at www.lisavienna.at.

LISAvienna UPDATE

Web: A brief summary including tips for SMEs interested in H2020 funds and some impressions of our business meeting in cooperation with Fit 4 Health 2.0 are available. Please also note that we now have 727 organizations in our online directory. Check out the latest entries submitted by Hartmann Law Firm, Improcess, Lithoz. and MyeloPro
Mark your calendar

Open Innovation in Pharma and Biotech
Vienna, November 17-18, 2016
Please contact Jürgen Fuchs to receive a discounted ticket.


TissueGnostics: Optics, Algos and Ice
Obergurgl, November 17-20, 2016


PERMIDES European Workshop: 60,000 euros per project for IT solutions for biopharma SMEs 
Vienna, December 15, 2016
Meet LISAvienna

Partnerships in Clinical Trials Europe - PCT 2016
Vienna, November 16-17, 2016
VIP code for special discount


Arab Health 2017
Dubai, January 30 - February 2, 2017
Contact Martin Mayer for details


HIMSS Conference & Exhibition 2017
Orlando, February 19-23, 2017
Contact Martin Mayer for details
Latest Publication

Chemiereport puts a spotlight on personalized medicine. Blood remains the most important source for biomedical analysis, but use of other bodily fluids and tissues is on the rise. Several Vienna based companies and research institutions have contributed to revolutionizing clinical research, diagnosis and treatment. Thermo Fisher for example runs its Center of Excellence for the development of immunoassays in Vienna. The article also stresses the importance of biomarkers and covers news from AIT, CBmed, Macroarray Diagnostics, Platomics, TAmiRNA and The Antibody Lab for example.
Enjoy reading!

More publications are available at www.lisavienna.at

FUNDING and SUPPORT

Vienna Business Agency: Co-creation lab 2017
Vienna based companies are invited to submit proposals for R&D projects they intend to carry out together with research institutes or other companies providing complementary expertise. Up to 500,000 euros are available per project plus a 10,000 euro extra bonus for research led by women. Are you interested in receiving updates from the Vienna Business Agency? Register for a free newsletter.

OPEN CALLS and DEADLINES

November 30, 2016: B&C – Houska Award
December 31, 2016: aws - Industry 4.0
January 19, 2017: WWTF - Environmental Systems Research Pilot Call 2017
January 31, 2017: EuroTransBio –Transnational R&D projects in biotechnology
March 14, 2017: Vienna Business Agency – Call Co-Create 2017

Register at lifesciences.europa@ffg.at for free mailings on European and other international funding initiatives in the life sciences.
Find additional deadlines at www.lisavienna.at

EVENTS in Vienna

FFG: Phönix Award Ceremony

November 22, 2016, Haus der Industrie, Schwarzenbergplatz 4, 1031 Vienna

BMVIT & FCIO: Produktion der Zukunft „Biobased Industry“

November 23, 2016, Gewerbehaus Wirtschaftskammer Wien, Rudolf-Sallinger-Platz 1, 1030 Vienna

IALSC: 17th World Conference on Lung Cancer

December 4-7, 2016, Messe Wien Exhibition & Congress Center, Messeplatz 1, 1021 Vienna
For more events be invited to www.lisavienna.at.
Your news placed here: Vienna-based organizations are invited to e-mail news and press releases to news@LISAvienna.at to contribute to LISAvienna's digital and print media.

Stay updated: Follow us on Twitter and LinkedIn and recommend our newsletter to colleagues and friends.
Copyright © LISAvienna 2016, All rights reserved.

Our mailing address is: office@LISAvienna.at

LISAvienna is the joint life science platform operated by austria wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry of Science, Research and Economy and the city of Vienna, LISAvienna contributes to the advancement of life sciences in Vienna.

unsubscribe from this list  |  update subscription preferences